These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10394018)

  • 1. Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Candida spp.
    Dupont B
    Chemotherapy; 1999 Jun; 45 Suppl 1():27-33. PubMed ID: 10394018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Aspergillus spp.
    Gurwith M
    Chemotherapy; 1999 Jun; 45 Suppl 1():34-8. PubMed ID: 10394019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of amphotericin B colloidal dispersion. An overview.
    Herbrecht R; Letscher V; Andres E; Cavalier A
    Chemotherapy; 1999 Jun; 45 Suppl 1():67-76. PubMed ID: 10394023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential treatment of deep fungal infections with amphotericin B deoxycholate and amphotericin B colloidal dispersion.
    Beović B; Lejko-Zupanc T; Pretnar J
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):507-11. PubMed ID: 9272385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.
    Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E
    Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B colloidal dispersion. Pre-clinical review.
    Working PK
    Chemotherapy; 1999 Jun; 45 Suppl 1():15-26. PubMed ID: 10394017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations.
    Linder N; Klinger G; Shalit I; Levy I; Ashkenazi S; Haski G; Levit O; Sirota L
    J Antimicrob Chemother; 2003 Oct; 52(4):663-7. PubMed ID: 12972450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal sparing by amphotericin B colloidal dispersion: clinical experience in 572 patients.
    Gurwith M; Mamelok R; Pietrelli L; Du Mond C
    Chemotherapy; 1999 Jun; 45 Suppl 1():39-47. PubMed ID: 10394020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant.
    Bowden RA; Cays M; Gooley T; Mamelok RD; van Burik JA
    J Infect Dis; 1996 May; 173(5):1208-15. PubMed ID: 8627074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
    Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP
    Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
    DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
    J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
    Noskin G; Pietrelli L; Gurwith M; Bowden R
    Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
    Colombo AL; Perfect J; DiNubile M; Bartizal K; Motyl M; Hicks P; Lupinacci R; Sable C; Kartsonis N
    Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):470-4. PubMed ID: 12884068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
    Herbrecht R; Letscher-Bru V; Bowden RA; Kusne S; Anaissie EJ; Graybill JR; Noskin GA; Oppenheim ; Andrès E; Pietrelli LA
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):460-6. PubMed ID: 11561801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of amphotericin B colloidal dispersion.
    Herbrecht R
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):74-80. PubMed ID: 9063677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 20. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.